Avience Biomedicals Schedules Board Meeting for Half-Yearly Results
Avience Biomedicals Ltd 路 Intimation 路 10 Nov 2026, 5:30 am
Avience Biomedicals Schedules Board Meeting for Half-Yearly Results Avience Biomedicals Limited has scheduled a meeting of its Board of Directors on 10th Nov'26 to consider, approve, and take on record the unaudited standalone and consolidated financial results for the half-year ended 30th Sep'26, alongside the Statutory Auditors' Limited Review Report. The board will also review certificates concerning the utilization of IPO proceeds and authorize key executives to submit the approved financial results and related documentation to the National Stock Exchange (NSE).
Original exchange filing (PDF)
More announcements from Avience Biomedicals Ltd
- Avience Biomedicals Limited has informed the Exchange about Link of Recording 路 18 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Investor Presentation 路 14 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Schedule of meet 路 12 Nov 2026
- Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 11 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 10 Nov 2026
- Avience Biomedicals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q 30 September, 2026 FY 2026-27 路 29 Oct 2026
- Avience Biomedicals Limited has informed the Exchange about Outcome of Investor Conference 路 02 Oct 2026
- Avience Biomedicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 01 Oct 2026
